In 2012, in response to IDF’s advocacy, Congress enacted the Medicare IVIG Access and Strengthening Medicare and Repaying Taxpayers Act of 2012 (PL 112-242) that created a special Medicare demonstration project to evaluate the impact of a permanent intravenous immunoglobulin (IVIG) home infusion Medicare benefit on costs of providing the benefit. The law directed Medicare […]
Follow the IDF Blog!We feature news and events related to the primary immunodeficiency community. If you have a story idea, contact us.
Sign-up for Blog Updates
Tag CloudAdvocacy Advocacy Channel Advocacy Volunteers Awareness Month Baxter International Inc. BioLife Biotest CSL Behring CSL Plasma CVS Caremark | Coram Specialty Infusion Services Grifols healthcare Health Care Costs Healthcare Reform Health Insurance IDF IDF Advocacy IDF Blue Jeans for Healthy Genes IDF Family Conference Day IDF Retreats IgG America | ASD Healthcare | US Bioservices Immune Deficiency Foundation Immunoglobulin Insurance Companies IVIG Legislation Medicare Medicare IVIG Octapharma Operation Outreach Patient Meeting PerkinElmer PI PI Community primary immune primary immunodeficiency primary immunodeficiency disease SCID Teens Vidara Therapeutics Volunteers Walgreens-IG Therapy Walk for PI World PI Week Zebras
Stay Informed Through IDF
IDF Social Media